Display options
Cite
Ridyard CH, Plumpton CO, Gilbert RE, et al. Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial. Front Pharmacol. 2017;8:644doi: 10.3389/fphar.2017.00644.
Ridyard, C. H., Plumpton, C. O., Gilbert, R. E., & Hughes, D. A. (2017). Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial. Frontiers in pharmacology, 8644. https://doi.org/10.3389/fphar.2017.00644
Ridyard, Colin H, et al. "Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial." Frontiers in pharmacology vol. 8 (2017): 644. doi: https://doi.org/10.3389/fphar.2017.00644
Ridyard CH, Plumpton CO, Gilbert RE, Hughes DA. Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial. Front Pharmacol. 2017 Sep 19;8:644. doi: 10.3389/fphar.2017.00644. eCollection 2017. PMID: 28974929; PMCID: PMC5610787.
Copy Download .nbib Format: NLM
Share it on

Front Pharmacol. 2017 Sep 19;8:644. doi: 10.3389/fphar.2017.00644. eCollection 2017.

Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial.

Frontiers in pharmacology

Colin H Ridyard, Catrin O Plumpton, Ruth E Gilbert, Dyfrig A Hughes

Affiliations

  1. Centre for Health Economics and Medicines Evaluation, Bangor Institute for Health and Medical Research, Bangor UniversityBangor, United Kingdom.
  2. UCL Institute of Child Health, University College LondonLondon, United Kingdom.

PMID: 28974929 PMCID: PMC5610787 DOI: 10.3389/fphar.2017.00644

[No abstract available.]

Keywords: antibiotic; bloodstream infection; central venous catheter; cost-effectiveness analysis; heparin; pediatric intensive care

References

  1. Pediatr Crit Care Med. 2010 Sep;11(5):579-87 - PubMed
  2. Pediatrics. 2014 Jun;133(6):e1525-32 - PubMed
  3. Intensive Care Med. 2014 Dec;40(12):1916-23 - PubMed
  4. Medicine (Baltimore). 2016 Mar;95(11):e3078 - PubMed
  5. Health Econ. 2011 Aug;20(8):897-916 - PubMed
  6. Crit Care. 2009;13(2):R35 - PubMed
  7. PLoS One. 2015 Aug 14;10(8):e0135672 - PubMed
  8. BMJ. 2013 Mar 25;346:f1049 - PubMed
  9. Health Econ. 2001 Dec;10(8):779-87 - PubMed
  10. JAMA. 1999 Aug 11;282(6):554-60 - PubMed
  11. Pediatrics. 2005 Apr;115(4):868-72 - PubMed
  12. Am J Infect Control. 2003 Feb;31(1):1-8 - PubMed
  13. Health Technol Assess. 2016 Mar;20(18):vii-xxviii, 1-219 - PubMed
  14. Pediatr Cardiol. 2010 May;31(4):483-9 - PubMed
  15. Value Health. 2015 Mar;18(2):161-72 - PubMed
  16. Intensive Care Med. 2003 Jan;29(1):139 - PubMed
  17. J Antimicrob Chemother. 2007 Mar;59(3):359-69 - PubMed
  18. Am J Infect Control. 2014 Nov;42(11):1157-60 - PubMed
  19. Chest. 2003 Jul;124(1):275-84 - PubMed
  20. Lancet. 2016 Apr 23;387(10029):1732-42 - PubMed
  21. PLoS One. 2016 Mar 21;11(3):e0151348 - PubMed
  22. Health Technol Assess. 2008 Apr;12 (12 ):iii-iv, xi-xii, 1-154 - PubMed
  23. Cochrane Database Syst Rev. 2015 Sep 27;(9):CD011078 - PubMed
  24. J Health Econ. 1999 Jun;18(3):341-64 - PubMed

Publication Types

Grant support